DGM-CM6: A New Model to Predict Distant Recurrence Risk in Operable Endocrine-Responsive Breast Cancer

Frontiers in Oncology
Lei LeiYunyun Zhou

Abstract

To investigate the prognostic value of DGM-CM6 (Distant Genetic Model-Clinical variable Model 6) for endocrine-responsive breast cancer (ERBC) patients, we analyzed 752 operable breast cancer patients treated in a Taiwan cancer center from 2005 to 2014. Among them, 490 ERBC patients (identified by the PAM50 or immunohistochemistry method) were classified by DGM-CM6 into low- and high-risk groups (cutoff <33 and ≥33, respectively). Significant differences were observed between the DGM-CM6 low- and high-risk groups for 10-year distant recurrence-free survival (DRFS) in both lymph node (LN)- (P < 0.05) and LN+ patients (P < 0.05). Multivariate analysis confirmed the independent strength of DGM-CM6 for the prediction of high- vs. low- risk groups for DRFS (P < 0.0001, HR: 6.76, 95% CI, 1.8-25.42) and overall survival (P = 0.01, HR: 6.06, 95% CI:1.55-23.47), respectively. In summary, DGM-CM6 may be used to classify low- and high-risk groups for 10-year distant recurrence in both LN- and LN+ ERBC patients in the Asian population. A large scale clinical trial is warranted.

References

Aug 30, 2000·Nature·C M PerouD Botstein
Nov 2, 2005·Breast Cancer Research and Treatment·D J BrittonR I Nicholson
Dec 20, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Melody A CobleighSteven Shak
May 25, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Soonmyung PaikNorman Wolmark
Dec 13, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Antonio C WolffUNKNOWN College of American Pathologists
Feb 9, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Joseph A Sparano, Soonmyung Paik
Feb 9, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Fatima CardosoMartine J Piccart-Gebhart
May 17, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Ben S WittnerSridhar Ramaswamy
Feb 11, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Joel S ParkerPhilip S Bernard
Jun 29, 2011·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A GoldhirschUNKNOWN Panel members
Aug 13, 2011·Breast Cancer Research and Treatment·Yahong WangYun Niu
Sep 9, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Nils D ArvoldJay R Harris
Jan 10, 2012·World Journal of Surgical Oncology·Hyung Seok ParkSang Seol Jung
Mar 16, 2013·Bioinformatics·Thierry RèmeBernard Klein
Sep 14, 2013·Journal of the National Cancer Institute·Ivana SestakJack Cuzick
Oct 26, 2013·British Journal of Cancer·P DubskyUNKNOWN Austrian Breast and Colorectal Cancer Study Group (ABCSG)
Feb 14, 2014·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Carol SweeneyBette J Caan
Feb 14, 2014·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Bette J CaanPhilip S Bernard
Jul 23, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Felipe AdesMartine Piccart
Aug 15, 2014·Polish Journal of Pathology : Official Journal of the Polish Society of Pathologists·Milica ColovićVladimir Jurišić
Aug 25, 2016·The New England Journal of Medicine·Fatima CardosoUNKNOWN MINDACT Investigators
Aug 26, 2016·World Journal of Surgical Oncology·Pattaraporn Wangchinda, Suthinee Ithimakin
Dec 22, 2016·Oncotarget·Zheng-Jun YangXu-Chen Cao
Feb 16, 2019·The Lancet Oncology·Sherene LoiUNKNOWN International Breast Cancer Study Group and the Breast International Group
Feb 21, 2019·Cytokine·Gordana M KonjevićVladimir B Jurišić
Jul 12, 2019·International Journal of Radiation Oncology, Biology, Physics·Tzu-Ting HuangSkye Hung-Chun Cheng

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Software Mentioned

genefu
affy package
R
EndoPredict
R genefu package

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.